DEVELOPMENT AND REGISTRATION OF A COMBINED DRUG FOR THE TREATMENT OF HIV INFECTION ON THE BASIS OF ON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTI) PHOSPHAZIDE AND LAMIVUDINE

The article discusses the development process of a combined medicinal product Phosphaladin® intended for the treatment of HIV infection, based on phosphazide and lamivudine. A brief review of epidemiological situation on HIV infection taking into account the import substitution policy in the pharmac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. F. Khohlov, B. V. Brovchenko, A. A. Smirnov
Formato: Artigo
Idioma:Russo
Publicado em: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Colecção:Разработка и регистрация лекарственных средств
Assuntos:
phosphazide
lamivudine
combined medicine
therapy of hiv infection
pharmaceutical development
Acesso em linha:https://www.pharmjournal.ru/jour/article/view/221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados